$560.00 - $14,859.50

$560.00 - $14.00

Choose an Option...
  • 100 mg - $14,859.50
  • 50 mg - $10,614.00
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

The 1A8-CP129 monoclonal antibody is a recombinant Fc-engineered chimeric version of the original 1A8 antibody. The variable domain sequences are identical to the original 1A8 hybridoma-derived antibody, but the constant region sequences have been switched from rat IgG2a to mouse IgG2a. 1A8-CP129 has been demonstrated to have superior Ly6G targeted cell depletion compared to the original hybridoma-derived antibody in-vivo. This antibody has an effector function competent Fc domain allowing for activation of Fcγ receptors (FcγRs) to trigger antibody‑dependent cellular cytotoxicity (ADCC), antibody‑dependent cellular phagocytosis (ADCP), complement‑dependent cytotoxicity (CDC) and opsonization to promote target cell depletion. Species-matched chimeric antibodies result in less immunogenicity and formation of anti-drug antibodies (ADAs) than xenogenic antibodies in animal models. The 1A8-CP129 monoclonal antibody reacts with mouse Ly6G, a 21-25 kDa member of the Ly-6 superfamily of GPI-anchored cell surface proteins with roles in cell signaling and cell adhesion. Ly6G is expressed differentially during development by cells in the myeloid lineage including monocytes, macrophages, granulocytes, and neutrophils. Monocytes typically express Ly6G transiently during development while mature granulocytes and peripheral neutrophils retain expression making Ly6G a good cell surface marker for these populations. Unlike the RB6-8C5 antibody, the 1A8-CP129 antibody reacts specifically with mouse Ly6G with no reported cross reactivity with mouse Ly6C.

Specifications

Isotype Mouse IgG2a, κ
Recommended Isotype Control(s) RecombiMAb mouse IgG2a isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Conjugation This product is unconjugated. Conjugation is available via our Antibody Conjugation Services.
Immunogen EL4J cells transfected with Ly6G
Reported Applications in vivo neutrophil depletion
in vivo MDSC depletion
Immunofluorescence*
Immunohistochemistry (paraffin)*
Immunohistochemistry (frozen)*
Flow cytometry*
*Reported for the original rat IgG2a 1A8 antibody
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from CHO cell supernatant in an animal-free facility
Purification Protein G
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Related Products

  1. Catalog #BP0075-1
    InVivoPlus anti-mouse Ly6G Read more
  2. Catalog #BE0075-1
    InVivoMAb anti-mouse Ly6G Read more

Additional Formats

  1. Catalog #BE0075-1
    InVivoMAb anti-mouse Ly6G Read more
  2. Catalog #BP0075-1
    InVivoPlus anti-mouse Ly6G Read more